Whoop Adds Blood Tests: Health Insights Beyond Wearables

Whoop, known for its screenless fitness tracker, has launched 'Advanced Labs,' a new initiative offering blood tests. Partnering with Quest Diagnostics, the company will test over 122 biomarkers related to heart, metabolic, and hormonal health. These tests are available a la carte, ranging from $69 to $299, and are separate from Whoop's existing membership fees. Customers can schedule tests at Quest locations after a doctor orders them via the Whoop app. Results are reviewed by a doctor, providing an action plan and AI-driven insights within the app. Advanced Labs is currently unavailable in Hawaii, Wyoming, South Dakota, and North Dakota. In New York, New Jersey, and Rhode Island, an additional state fee applies per panel.

Alongside its lab testing expansion, Whoop has introduced the Galleri multicancer early detection test. Developed by Grail, this $799 test screens for signals of over 50 cancer types. It is recommended for adults with elevated cancer risk, such as those aged 50 and older, but is not a diagnostic tool and should not replace routine screenings. The Galleri test requires blood to be drawn at a Quest location and processed at Grail's lab. This strategic move by Whoop, offering one-time priced health services beyond its wearable, may indicate a broader industry trend towards integrated health platforms.